Stock VAXX VAXXINITY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Vaxxinity, Inc.

Equities

VAXX

US92244V1044

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
0.1042 USD -9.08% Intraday chart for Vaxxinity, Inc. -21.42% -87.74%
04-22 Sector Update: Health Care Stocks Advance Premarket Monday MT
04-22 Sector Update: Health Care MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sector Update: Health Care Stocks Advance Premarket Monday
MT
Sector Update: Health Care
MT
Vaxxinity Issues Shareholder Letter
AQ
Vaxxinity Issues Shareholder Letter
GL
Vaxxinity to Voluntarily Delist From Nasdaq; Shares Sink After Hours
MT
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
GL
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
GL
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
GL
Vaxxinity, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
North American Morning Briefing : Tech in Focus on -2-
DJ
Vaxxinity : UB-312 Target Engagement - ADPD 2024
PU
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
GL
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson?s Disease at AD/PD? 2024
CI
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
GL
Vaxxinity, Inc. Announces the Publication of Data from Multiple Non-Human Primate Studies
CI
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
GL
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
AQ
Vaxxinity, Inc. to Present Data from UB-312 Program in Parkinson's Disease at International Conference on Alzheimer's and Parkinson's Diseases and Related Neurolog Disorders
CI
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
GL
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VAXX Stock
  4. News Vaxxinity, Inc.